OBERLAND CAPITAL
Oberland Capital provides innovative financing solutions to companies and royalty holders in the healthcare industry. We specialize in flexible investment structures customized to meet the specific capital requirements and strategic objectives of transaction partners globally. Our broad suite of financing solutions includes monetization of royalty streams, acquisition of future product revenues, creation of project-based financing structures, and investment in debt and equity securities. With a combination of deep industry knowledge and extensive structured finance experience, the Oberland Capital team has a history of creating value for our transaction partners.
OBERLAND CAPITAL
Social Links:
Industry:
Asset Management Financial Services Venture Capital
Founded:
2013-01-01
Status:
Active
Contact:
212-257-5850
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Content Delivery Network Google Universal Analytics Font Awesome Mobile Non Scaleable Content Sitelinks Search Box Google Maps
Similar Organizations
Equinox Capital
Equinox Capital provides its services to investment companies.
FlatWorld Capital
FlatWorld Capital provides financing solutions to middle-market companies.
Tahoma Ventures
Tahoma Ventures provides early stage capital to IT technology startups.
Third Eye Capital
Third Eye Capital provides innovative and customized lending solutions for companies.
TMT Investments
TMT Investments provides investors with liquid exposure to a diversified portfolio of earlier-stage technology startups.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-12-14 | Zealand Pharma | Oberland Capital investment in Post-IPO Debt - Zealand Pharma | 200 M USD |
| 2021-10-04 | Centessa Pharmaceuticals | Oberland Capital investment in Post-IPO Debt - Centessa Pharmaceuticals | 300 M USD |
| 2021-04-26 | Esperion | Oberland Capital investment in Post-IPO Equity - Esperion | 50 M USD |
| 2020-12-09 | Mirum Pharmaceuticals | Oberland Capital investment in Post-IPO Equity - Mirum Pharmaceuticals | 10 M USD |
| 2020-10-27 | Primmune Therapeutics | Oberland Capital investment in Series A - Primmune Therapeutics | 27.4 M USD |
| 2019-04-23 | NorthStar Medical Radioisotopes | Oberland Capital investment in Venture Round - NorthStar Medical Radioisotopes | 75 M USD |
| 2017-10-26 | Impact Biomedicines | Oberland Capital investment in Debt Financing - Impact Biomedicines | 90 M USD |
| 2017-06-29 | Melinta Therapeutics | Oberland Capital investment in Post-IPO Equity - Melinta Therapeutics | 90 M USD |